MX2023001756A - Peptidos funcionalizados como agentes antivirales. - Google Patents
Peptidos funcionalizados como agentes antivirales.Info
- Publication number
- MX2023001756A MX2023001756A MX2023001756A MX2023001756A MX2023001756A MX 2023001756 A MX2023001756 A MX 2023001756A MX 2023001756 A MX2023001756 A MX 2023001756A MX 2023001756 A MX2023001756 A MX 2023001756A MX 2023001756 A MX2023001756 A MX 2023001756A
- Authority
- MX
- Mexico
- Prior art keywords
- formula
- pharmaceutically acceptable
- antiviral agents
- subject
- compound
- Prior art date
Links
- 239000003443 antiviral agent Substances 0.000 title 1
- 102000004196 processed proteins & peptides Human genes 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
- 150000001875 compounds Chemical class 0.000 abstract 3
- 150000003839 salts Chemical class 0.000 abstract 2
- 241000711573 Coronaviridae Species 0.000 abstract 1
- 208000001528 Coronaviridae Infections Diseases 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000010076 replication Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
- C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
- C07K5/06—Dipeptides
- C07K5/06139—Dipeptides with the first amino acid being heterocyclic
- C07K5/06156—Dipeptides with the first amino acid being heterocyclic and Trp-amino acid; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Organic Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Biophysics (AREA)
- Genetics & Genomics (AREA)
- Virology (AREA)
- Biochemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Communicable Diseases (AREA)
- Immunology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Engineering & Computer Science (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Plural Heterocyclic Compounds (AREA)
- Medicinal Preparation (AREA)
Abstract
La presente invención describe compuestos de la Fórmula (I) y sales farmacéuticamente aceptables de los mismos: que inhiben la actividad de replicación del coronavirus. La invención se refiere además a composiciones farmacéuticas que comprenden un compuesto de la Fórmula (I) o una sal farmacéuticamente aceptable del mismo, y métodos para tratar o prevenir una infección por coronavirus en un sujeto que lo necesite, que comprenden administrar al sujeto una cantidad terapéuticamente efectiva de un compuesto de la Fórmula (I) o una sal farmacéuticamente aceptable del mismo.
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US202063065283P | 2020-08-13 | 2020-08-13 | |
| PCT/US2021/045632 WO2022036018A1 (en) | 2020-08-13 | 2021-08-12 | Functionalized peptides as antiviral agents |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| MX2023001756A true MX2023001756A (es) | 2023-05-04 |
Family
ID=80223910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| MX2023001756A MX2023001756A (es) | 2020-08-13 | 2021-08-12 | Peptidos funcionalizados como agentes antivirales. |
Country Status (12)
| Country | Link |
|---|---|
| US (1) | US20220048944A1 (es) |
| EP (1) | EP4196117A1 (es) |
| JP (1) | JP2023537402A (es) |
| KR (1) | KR20230070207A (es) |
| CN (1) | CN116547294A (es) |
| AU (1) | AU2021324764A1 (es) |
| BR (1) | BR112023002573A2 (es) |
| CA (1) | CA3189248A1 (es) |
| CO (1) | CO2023002852A2 (es) |
| IL (1) | IL300589A (es) |
| MX (1) | MX2023001756A (es) |
| WO (1) | WO2022036018A1 (es) |
Families Citing this family (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20230124583A (ko) | 2020-11-23 | 2023-08-25 | 이난타 파마슈티칼스, 인코포레이티드 | 신규한 스피로피롤리딘 유래 항바이러스제 |
| WO2022235605A1 (en) | 2021-05-04 | 2022-11-10 | Enanta Pharmaceuticals, Inc. | Novel macrocyclic antiviral agents |
| US11753373B2 (en) * | 2021-06-02 | 2023-09-12 | ACEA Therapeutics, Inc. | Protease inhibitors as antivirals |
| US20230033285A1 (en) * | 2021-06-16 | 2023-02-02 | The Scripps Research Institute | Protease Inhibitors for Treatment of Coronavirus Infections |
| US11919910B2 (en) | 2021-11-12 | 2024-03-05 | Enanta Pharmaceuticals, Inc. | Spiropyrrolidine derived antiviral agents |
| WO2023086352A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Novel spiropyrrolidine derived antiviral agents |
| WO2023086350A1 (en) | 2021-11-12 | 2023-05-19 | Enanta Pharmaceuticals, Inc. | Alkyne-containing antiviral agents |
| WO2023107419A1 (en) | 2021-12-08 | 2023-06-15 | Enanta Pharmaceuticals, Inc. | Saturated spirocyclics as antiviral agents |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2850003C (en) * | 2011-09-27 | 2020-01-07 | Kansas State University Research Foundation | Broad-spectrum antivirals against 3c or 3c-like proteases of picornavirus-like supercluster: picornaviruses, caliciviruses and coronaviruses |
| US11124497B1 (en) * | 2020-04-17 | 2021-09-21 | Pardes Biosciences, Inc. | Inhibitors of cysteine proteases and methods of use thereof |
-
2021
- 2021-08-12 CN CN202180069618.1A patent/CN116547294A/zh active Pending
- 2021-08-12 JP JP2023509720A patent/JP2023537402A/ja active Pending
- 2021-08-12 EP EP21856680.0A patent/EP4196117A1/en active Pending
- 2021-08-12 BR BR112023002573A patent/BR112023002573A2/pt unknown
- 2021-08-12 WO PCT/US2021/045632 patent/WO2022036018A1/en active Application Filing
- 2021-08-12 AU AU2021324764A patent/AU2021324764A1/en active Pending
- 2021-08-12 US US17/400,190 patent/US20220048944A1/en not_active Abandoned
- 2021-08-12 MX MX2023001756A patent/MX2023001756A/es unknown
- 2021-08-12 CA CA3189248A patent/CA3189248A1/en active Pending
- 2021-08-12 KR KR1020237008606A patent/KR20230070207A/ko unknown
- 2021-08-12 IL IL300589A patent/IL300589A/en unknown
-
2023
- 2023-03-08 CO CONC2023/0002852A patent/CO2023002852A2/es unknown
Also Published As
| Publication number | Publication date |
|---|---|
| AU2021324764A1 (en) | 2023-03-16 |
| BR112023002573A2 (pt) | 2023-03-14 |
| IL300589A (en) | 2023-04-01 |
| JP2023537402A (ja) | 2023-08-31 |
| KR20230070207A (ko) | 2023-05-22 |
| CA3189248A1 (en) | 2022-02-17 |
| US20220048944A1 (en) | 2022-02-17 |
| WO2022036018A1 (en) | 2022-02-17 |
| EP4196117A1 (en) | 2023-06-21 |
| CO2023002852A2 (es) | 2023-06-09 |
| CN116547294A (zh) | 2023-08-04 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| MX2023000798A (es) | Peptidos funcionalizados como agentes antivirales. | |
| MX2023005984A (es) | Nuevos agentes antivirales derivados de la espiropirrolidina. | |
| MX2023001756A (es) | Peptidos funcionalizados como agentes antivirales. | |
| MX2023005983A (es) | Nuevos agentes antivirales derivados de la espiropirrolidina. | |
| MY196455A (en) | Nitrile-Containing Compounds Useful as Antiviral Agents for The Treatment of a Coronavirus Infection | |
| ZA202109010B (en) | Compounds and methods for the treatment of covid-19 | |
| TW200518758A (en) | HIV replication inhibiting purine derivatives | |
| MX2009006764A (es) | Pirimidinonas biciclicas y usos de la misma. | |
| TW200639159A (en) | Treatment of pain | |
| MX2020010300A (es) | Sales monoacidas de 6-aminoisoquinolinas y usos de las mismas. | |
| MX2012000488A (es) | Terapia de combinacion para el tratamiento de la diabetes. | |
| MX2010007374A (es) | Nuevos derivados de c-21-ceto lupano, preparacion y uso de los mismos. | |
| SE9901573D0 (sv) | New compounds | |
| WO2021168483A3 (en) | Treatment of human coronavirus infections using alpha-glucosidase glycoprotein processing inhibitors | |
| MX2021014372A (es) | Compuestos derivados de 1,3,4-oxadiazol como inhibidores de histona desacetilasa 6, y la composicion farmaceutica que comprende los mismos. | |
| MX2021015543A (es) | Derivado de pirimidina que inhibe el crecimiento de celulas cancerosas y uso medicinal del mismo. | |
| MX2022006333A (es) | Compuesto triheterociclico como inhibidor de jak y uso del mismo. | |
| JOP20220227A1 (ar) | مركبات بيرولو بيريميدين أمينات كمثبطات للمُتَمِّمِة | |
| CR20220538A (es) | Compuestos y composiciones para inhibir la actividad de hif2-alfa y sus métodos de uso | |
| MX2022009967A (es) | Compuestos para el tratamiento de la infeccion por coronavirus. | |
| MX2021011144A (es) | Derivados de las benzodiazepinas como inhibidores del vsr. | |
| MX2022003845A (es) | Tratamientos cognitivos medicinales. | |
| SE9901572D0 (sv) | New compounds | |
| MX2022011240A (es) | Azálidos de urea inmunomoduladores. | |
| EA202193211A1 (ru) | Лечение синуклеопатий |